Request Demo
Last update 20 Mar 2025
Gliclazide/Metformin Hydrochloride
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 二甲双胍格列齐特 |
Target |
Action activators, agonists |
Mechanism PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators), SUR agonists(Sulfonylurea receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date China (22 Sep 2005), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC15H21N3O3S |
InChIKeyBOVGTQGAOIONJV-UHFFFAOYSA-N |
CAS Registry21187-98-4 |
View All Structures (2)
Related
4
Clinical Trials associated with Gliclazide/Metformin HydrochlorideCTR20202686
二甲双胍格列吡嗪片单中心、开放、随机、单剂量、两周期、两序列、交叉生物等效性研究
[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study of metformin and glipizide tablets
NCT03467971
A Randomized, Open-label, Single Dose, 2x2 Crossover Trial to Evaluate the Food Effect on the Bioavailability of a Metformin/Gliclazide Fixed Combination Tablet (1000 mg /30 mg MR) Given in Fasting and Fed Conditions to Healthy Volunteers
NCT03467945
Randomized, Open Label, Single Dose, 4 Treatment, 4 Period, Crossover Design (4 x 4) Trial to Evaluate the Bioequivalence and Secondarily Drug - Drug Interaction of Fixed Combination of Metformin Tablets 1000 mg/Gliclazide 30 mg MR, Compared With the Co-administration of Individual Tablets and Individual Administration of Each Single Tablet (Metformin 1000 mg XR and Gliclazide 30 mg MR) in Healthy Volunteers
100 Clinical Results associated with Gliclazide/Metformin Hydrochloride
Login to view more data
100 Translational Medicine associated with Gliclazide/Metformin Hydrochloride
Login to view more data
100 Patents (Medical) associated with Gliclazide/Metformin Hydrochloride
Login to view more data
100 Deals associated with Gliclazide/Metformin Hydrochloride
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | China | 22 Sep 2005 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 110 | nhvozfyvjl(kiuhmbwvlr) = wqirzarruj upludbhoas (ngmwlvjfle ) View more | - | 20 Jun 2023 | |||
nhvozfyvjl(kiuhmbwvlr) = xwrkeuajla upludbhoas (ngmwlvjfle ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free